Price
Target price
€1.00
€1.00
-2.870%
-0.0295
-2.870%
€3.65
25.04.24 / Tradegate
WKN: A1W77U / Symbol: KPTI / Name: Karyopharm / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Karyopharm Therapeutics Inc. Stock
We can see a decrease in the price for Karyopharm Therapeutics Inc.. Compared to yesterday it has lost -€0.030 (-2.870%).
With 7 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
Based on the current price of 1.0 € the target price of 3 € shows a potential of 200.72% for Karyopharm Therapeutics Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Karyopharm Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Unique positioning" there were negative voices in the community.
Pros and Cons of Karyopharm Therapeutics Inc. in the next few years
Pros
?
M***** P*******
?
B****
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Karyopharm Therapeutics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. | -2.870% | -3.707% | -21.941% | -73.706% | 19.731% | -87.539% | - |
Ardelyx Inc. | -2.390% | -2.578% | -17.883% | 40.048% | 2.007% | -13.927% | - |
Salarius Pharmaceuticals Inc. | -3.170% | -2.727% | -46.500% | -69.209% | -22.883% | -98.244% | -99.994% |
Brainstorm Cell | 1.170% | 3.754% | -21.032% | -81.975% | 114.440% | -80.717% | - |
Comments
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target lowered by analysts at Royal Bank of Canada from $4.00 to $3.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for KPTI provided by MarketBeat
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target lowered by analysts at Royal Bank of Canada from $5.00 to $4.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for KPTI provided by MarketBeat
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Show more
Ratings data for KPTI provided by MarketBeat
News
Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript
Karyopharm Therapeutics (NASDAQ: KPTI)Q4 2023 Earnings CallFeb 29, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Karyopharm Therapeutics (KPTI) Q3 2023 Earnings Call Transcript
Karyopharm Therapeutics (NASDAQ: KPTI)Q3 2023 Earnings CallNov 02, 2023, 8:00 a.m. ET
Operator
Source Fool.com